Report Categories
View AllRecent Articles
View All
FCPT Four shares post small gain after Q4 2025 EPS falls slightly short of consensus analyst estimates
BFRGW Bullfrog AI prioritizes AIpowered healthcare solution rollouts in its latest quarterly earnings update
GANX Gain Therapeutics posts narrower Q4 2025 loss than estimates but shares fall 239
MDB MongoDB Q1 2026 EPS tops estimates shares rise 31 percent on 228 percent year over year revenue growth
FFIV F5 delivers solid Q1 2026 earnings shares tick up on 195 EPS surprise and 97 yearoveryear revenue growth
EURKR Eureka reports quarterly results with no published EPS or revenue data as investors await further strategic updates
Pimco High PHK Stock Bracket Order Slow Grind 20260420
Public Service Enterprise Group PEG Declares Steady Q2 2026 Quarterly Dividend Signaling Resilient Regulated Utility Cash Flow
MIAX Miami Q4 2025 earnings deliver 243 percent EPS surprise shares fall 211 percent despite strong revenue growth
SNN Smith and posts narrow Q4 2014 earnings beat shares dip 03 percent despite 61 percent revenue growth
Addus ADUS Stock Gift Technical Weakness 20260420
iShares Core SP SmallCap ETF IJR Impending Earnings Growth Inflection Signals MultiYear Outperformance Potential
Health Catalyst HCAT Stock Pending Order Volatility Increases 20260422
Faraday FFAIW Stock Why Switching Cost Near Highs 20260420
TNL Mediagene TNMG Stock Winter Outlook 310 20260420
NUE Nucor Corporation posts 103 percent Q4 2025 EPS miss shares rise modestly despite soft quarterly performance
How do interest rates affect Tenax Therapeutics TENX stock Q4 2025 Profit Exceeds Views
KLA Corporation KLAC Q3 2026 Earnings Preview Segmental and Geographic Trends Signal Robust TopLine Growth Trajectory
External Links
Is Virtus VGI stock a good candidate for diversification Quiet 20260420
WBDParamount Merger Shareholder Vote Outcome and ForwardLooking Risks
Exxon Mobil Corporation XOM Implements AboveExpectation Plastics Price Hikes Amid Geopolitical Supply Disruptions
WMK Weis Markets drops 303 after Q3 2023 earnings release offers no consensus performance comparisons
TECH BioTechne gains 38 percent after Q1 2026 earnings per share outpace consensus analyst estimates